These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 6710954)

  • 1. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer].
    Polevaia EB; Tkacheva GA; Ivanov VM; Koposova TL
    Vopr Onkol; 1984; 30(3):9-13. PubMed ID: 6710954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of the measurement of tissue polypeptide antigen in patients with breast cancer].
    Fukunaga M; Otsuka N; Yanagi M; Sone T; Muranaka A; Yanagimoto S; Tomomitsu T; Morita R; Ohama T; Sonoo H
    Gan No Rinsho; 1985 Jul; 31(8):923-8. PubMed ID: 4032770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
    Kausitz J; Hupka S; Makaiová I; Michalíková B; Urbanová M; Bohunický L; Belovicová C
    Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V; Björklund B
    Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human tissue polypeptide antigen in breast cancer.
    Nemoto T; Constantine R; Chu TM
    J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The tumor markers TPA and CEA in the after care of breast cancer].
    Beaufort F; Fueger GF; Steiner H
    Wien Med Wochenschr; 1985 Feb; 135(4):85-8. PubMed ID: 2986366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
    Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
    Paulick R; Caffier H; Paulick M
    Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage.
    Salvati F; Antilli A; Cruciani AR; Pau F; Flore F; Munno R; De Angelis G; Cipri A; Pigorini F
    Cancer Detect Prev; 1985; 8(1-2):111-4. PubMed ID: 4064030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical aspects of the radioimmunoassay of carcinoembryonic antigen levels in breast cancer].
    Agranat VZ; Baliura AV; Nikogosian GA; Smolina TA; Iass NIa
    Med Radiol (Mosk); 1983 Aug; 28(8):34-7. PubMed ID: 6888209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of tissue polypeptide antigen in breast cancer patients.
    Mross K; Bandlow G
    Anticancer Res; 1986; 6(2):223-5. PubMed ID: 3707059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CEA and TPA in cancer of the breast. Findings and criteria of use].
    Torres Avisbal M; Ruíz de Almodovar Rivera JM; Villalba Moreno J; Olea Serrano N; Padilla Bolivar O; Pedraza Muriel V
    Rev Esp Oncol; 1985; 32(2):265-80. PubMed ID: 3843460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].
    Meregalli M; Antoniazzi V; Torchio G; Colombo E; Bocchi M; Sonzini E; Lino S
    Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioimmunoassay of carcinoembryonic antigen in the evaluation of the effectiveness of breast cancer treatment].
    Polevaia EB; Ivanov VM; Koposova TL; Gabuniia RI; Chinareva IV
    Vopr Onkol; 1984; 30(4):23-9. PubMed ID: 6730403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of a combination assay of CEA, CA-19-9 and TPA in patients with colorectal cancer].
    Nishida O; Shiroto H; Satoh N; Nakajima Y; Manabe K; Kondoh Y; Sano F; Uchino J
    Gan No Rinsho; 1988 Aug; 34(9):1096-100. PubMed ID: 3172515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
    Bombardieri E; Jotti GS; Cocciolo MG; Mori M; Rusconi A; Rusca M; Seregni E; Becchi G; Fontanesi M; Tardini A
    Cancer Detect Prev; 1985; 8(1-2):219-26. PubMed ID: 4064041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tumour markers CA50, CEA and TPA in female breast carcinoma as related to histopathological findings and survival.
    Eskelinen M; Lipponen P; Syrjänen K
    Anticancer Res; 1992; 12(1):91-5. PubMed ID: 1567186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of a tumor marker NCC-ST-439 in breast cancer--a comparative study with CA 15-3, CEA and TPA].
    Okamura Y; Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1279-85. PubMed ID: 2069399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance.
    Lüthgens M; Schlegel G
    Cancer Detect Prev; 1983; 6(1-2):51-9. PubMed ID: 6883393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.